Burning Feet After Iron Infusion in Dumping Syndrome Patient
Burning sensation in the feet is not a recognized direct adverse effect of intravenous iron infusion, but the symptom warrants immediate evaluation for alternative causes including hypophosphatemia, peripheral neuropathy from underlying nutritional deficiencies, or unrelated pathology.
Understanding the Clinical Context
The 2024 expert consensus guidelines on IV iron comprehensively detail recognized adverse reactions, and burning feet is notably absent from the documented spectrum of infusion reactions 1. The guidelines classify reactions into:
- Mild reactions: Pruritus, flushing, urticaria, chest tightness, back pain, joint pain
- Moderate reactions: Transient cough, shortness of breath, tachycardia, hypotension
- Severe reactions: Anaphylaxis with multi-organ involvement
Burning feet does not appear in any category of documented IV iron reactions.
Critical Differential Diagnoses to Evaluate
1. Treatment-Emergent Hypophosphatemia (Most Important)
This is the most likely IV iron-related cause that could manifest with neurological symptoms 1, 2:
- Occurs within 2 weeks of certain IV iron formulations, particularly ferric carboxymaltose (FCM)
- Incidence: 47-75% with FCM, <10% with other formulations
- Symptoms include: Fatigue, proximal muscle weakness, bone pain, myopathy
- Can persist up to 6 months with severe cases
- Action: Check serum phosphate immediately; if <2.5 mg/dL, this may explain symptoms
2. Delayed Musculoskeletal Reactions
The guidelines describe delayed reactions occurring hours to days post-infusion 1:
- Flu-like symptoms, arthralgias, myalgias lasting up to 24 hours
- Managed with NSAIDs
- However, symptoms lasting >few days require evaluation for other pathologies
- One case report documented rhabdomyolysis with severe leg pain and muscular stiffness after ferric gluconate 3
3. Underlying Nutritional Neuropathy
Patients with dumping syndrome often have:
- Multiple nutritional deficiencies (B12, thiamine, folate)
- Burning feet syndrome is classically associated with B-vitamin deficiencies 4
- The dumping syndrome itself does not cause burning feet 5, 6
Recommended Clinical Approach
Immediate Assessment:
Laboratory evaluation:
- Serum phosphate (priority)
- Creatine kinase (rule out rhabdomyolysis)
- Complete metabolic panel
- Vitamin B12, folate, thiamine levels
- Hemoglobin A1c (rule out diabetic neuropathy)
Physical examination specifics:
- Assess for muscle weakness, particularly proximal muscles
- Check for bone tenderness
- Neurological examination for sensory deficits
- Vital signs to rule out ongoing infusion reaction
Management Algorithm:
If hypophosphatemia confirmed (<2.5 mg/dL):
- Phosphate supplementation
- Switch to alternative IV iron formulation for future needs (avoid FCM)
- Monitor phosphate levels until normalized
If normal phosphate:
- Investigate nutritional deficiencies aggressively
- Consider neurology referral if symptoms persist
- Document as potential atypical reaction; report to pharmacovigilance
If symptoms worsen or new symptoms develop:
- Rule out evolving infusion reaction (though timing makes this unlikely)
- Consider alternative diagnoses unrelated to iron infusion
Critical Caveats
- Temporal association does not equal causation: The timing after iron infusion may be coincidental
- Dumping syndrome patients are at high risk for multiple nutritional deficiencies that could independently cause burning feet
- The safety profile of IV iron is well-established with no increased risk of serious adverse events overall 7
- Do not dismiss symptoms: While not a recognized IV iron reaction, symptoms lasting >few days require thorough evaluation 1
The most prudent approach is to check serum phosphate immediately while simultaneously evaluating for nutritional neuropathies common in dumping syndrome patients, rather than attributing symptoms directly to the iron infusion without evidence.